STAT July 25, 2024
Rachel Cohrs Zhang

Pharma locks in on North Carolina

The pharmaceutical industry has lost some longtime allies in recent years. By the looks of it, executives and lobbyists are looking to North Carolina to make some new ones, according to federal campaign finance disclosures. Recall that a freshman Democratic lawmaker from North Carolina, Rep. Don Davis, was willing to stick his neck out and sponsor a policy to water down Democrats’ drug pricing reform bill...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article